Paulson, Margaret R.
Torres-Guzman, Ricardo A.
Avila, Francisco R.
Maita, Karla C.
Garcia, John P.
Forte, Antonio J.
Matcha, Gautam V.
Pagan, Ricardo J.
Maniaci, Michael J.
Article History
Received: 21 August 2022
Accepted: 23 March 2023
First Online: 27 March 2023
Declarations
:
: This study was approved by the Mayo Clinic Institutional Review Board as a retrospective chart review under protocol number 20–010753 and analyzed the de-identified patient data under protocol number 21–004666. Patients provide both oral and written informed consent to participate in the ACH program and this ACH research study. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: No authors have any personal or financial conflicts of interest to declare. All authors are full-time employees of Mayo Clinic, which in turn has an ownership interest in a joint venture with Medically Home, a technology company that enables acute health care delivery provided to patients in their homes. Dr. Maniaci serves as Mayo Clinic’s representative on the Medically Home Board of Directors; this is an unpaid position. No authors have any personal financial interest Medically Home or receive any royalties through Mayo Clinic as part of the venture.